ANKRD44 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.133200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.116600E-01
Normal-vs-Stage2
4.172200E-01
Normal-vs-Stage3
3.692800E-01
Normal-vs-Stage4
4.436400E-01
Stage1-vs-Stage2
8.973000E-01
Stage1-vs-Stage3
2.959600E-01
Stage1-vs-Stage4
4.928200E-01
Stage2-vs-Stage3
2.850300E-02
Stage2-vs-Stage4
6.967400E-01
Stage3-vs-Stage4
4.718300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.123000E-01
Normal-vs-AfricanAmerican
5.259000E-01
Normal-vs-Asian
3.569000E-01
Caucasian-vs-AfricanAmerican
5.416200E-02
Caucasian-vs-Asian
3.403400E-03
AfricanAmerican-vs-Asian
7.181600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.055200E-01
Normal-vs-Female
4.235000E-01
Male-vs-Female
3.255600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.309000E-01
Normal-vs-Age(41-60Yrs)
4.244800E-01
Normal-vs-Age(61-80Yrs)
4.122400E-01
Normal-vs-Age(81-100Yrs)
3.736200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.439400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.303000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.438760E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.160800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.522240E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.006300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.064200E-01
Normal-vs-Daily Drinker
3.668200E-01
Normal-vs-Weekly Drinker
3.870400E-01
Normal-vs-Occasional Drinker
4.043200E-01
Normal-vs-Social Drinker
4.364800E-01
Non Drinker-vs-Daily Drinker
1.014550E-01
Non Drinker-vs-Weekly Drinker
4.912400E-01
Non Drinker-vs-Occasional Drinker
9.540200E-01
Non Drinker-vs-Social Drinker
4.798000E-01
Daily Drinker-vs-Weekly Drinker
2.389200E-01
Daily Drinker-vs-Occasional Drinker
7.147500E-02
Daily Drinker-vs-Social Drinker
6.204100E-02
Weekly Drinker-vs-Occasional Drinker
4.980400E-01
Weekly Drinker-vs-Social Drinker
2.149400E-01
Occasional Drinker-vs-Social Drinker
4.172000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.031800E-01
Normal-vs-Grade 2
2.706000E-01
Normal-vs-Grade 3
2.344000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.667600E-01
Grade 1-vs-Grade 3
3.951800E-01
Grade 1-vs-Grade 4
4.031800E-01
Grade 2-vs-Grade 3
5.920600E-01
Grade 2-vs-Grade 4
2.706000E-01
Grade 3-vs-Grade 4
2.344000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.270600E-01
Normal-vs-NonDiabetic
3.901400E-01
Diabetic-vs-NonDiabetic
4.125500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.797800E-01
Normal-vs-NoPancreatitis
4.044000E-01
Pancreatitis-vs-NoPancreatitis
7.955900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.174200E-01
Normal-vs-N1
4.133000E-01
N0-vs-N1
8.704600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.600000E-01
Normal-vs-TP53-NonMutant
4.297400E-01
TP53-Mutant-vs-TP53-NonMutant
5.122300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
